Navigation Links
Hiker without Human Heart Receives Heart Transplant 607 Miles Later

TUCSON, Ariz., Nov. 15, 2012 /PRNewswire/ -- SynCardia Systems, Inc. (, manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that avid hiker Chris Marshall, who received the SynCardia temporary Total Artificial Heart in February, has been successfully bridged to a heart transplant at University of Washington (UW) Medical Center in Seattle.


Watch video from NBC Seattle -

"I walked 607 miles with the Total Artificial Heart, so I was really fit going into that surgery," said Mr. Marshall, who received his heart transplant on Sept. 12. "That's very different from a lot of people who go into the transplant really sick. After the surgery, they not only have to recover from the transplant, but also from being sick for so long leading up to it."

Mr. Marshall was implanted with the SynCardia Total Artificial Heart on Feb. 6. Seven weeks later, on March 21, he became the first Total Artificial Heart patient in the Pacific Northwest to be discharged from the hospital using the Freedom® portable driver to power his Total Artificial Heart. After his discharge, Mr. Marshall hiked daily in the Seattle area with his wife Kathy and their golden retriever Gracie.

When asked what advice he has for other Total Artificial Heart patients, Mr. Marshall said, "Don't go home and stay cooped up. You need to get out and take advantage of the time you have to get in shape to prepare for the transplant surgery and live life. Some people are afraid. The only thing they want to do is be home or go to the clinic for visits, but for me, that's not living life."

In 1999, Mr. Marshall was diagnosed with cardiomyopathy, a disease that destroys the heart muscle over time, and ventricular tachycardia, an irregular, fast heartbeat. Although his implanted defibrillator shocked his heart 30 times over a 12-year span, Mr. Marshall never let his heart condition slow him down. He continued to hike three to five miles daily, despite his ejection fraction being only 20%.

However, last fall, he started experiencing shortness of breath while hiking on level ground, which had never happened before. On Jan. 23, Mr. Marshall and his wife Kathy traveled from their home in Wasilla, Alaska, to Seattle for what was supposed to be a one-day heart evaluation. Doctors discovered his heart was functioning at less than 10 percent, and didn't think he would survive the flight home.

Mr. Marshall was not a candidate for a left ventricular assist device (LVAD) - a mechanical pump that supports only the left side of the heart - because the right side of his heart was too weak. His doctors decided the SynCardia Total Artificial Heart was his only option for survival.

Weighing 13.5 pounds (~6 kg), the Freedom portable driver is the world's first wearable power supply for the SynCardia Total Artificial Heart. The Freedom portable driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S.

Read article in The Seattle Times -

View press release from UW Medical Center -

CAUTION – The Freedom portable driver is an investigational device, limited by United States law to investigational use.

Like SynCardia on Facebook
Follow SynCardia on Twitter – @SynCardia
Connect with SynCardia on LinkedIn

About the SynCardia temporary Total Artificial Heart

SynCardia Systems, Inc. (Tucson, AZ) is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart, SynCardia's Total Artificial Heart is currently approved as a bridge to transplant for people dying from end-stage biventricular heart failure. There have been more than 1,000 implants of the Total Artificial Heart, accounting for more than 270 patient years of life.

Similar to a heart transplant, SynCardia's Total Artificial Heart replaces both failing heart ventricles and the four heart valves, eliminating the symptoms and source of end-stage biventricular failure. Unlike a donor heart, the Total Artificial Heart is immediately available at SynCardia Certified Centers. It is the only device that provides immediate, safe blood flow of up to 9.5 liters per minute through each ventricle. This high volume of safe blood flow helps speed the recovery of vital organs, helping make the patient a better transplant candidate.



SOURCE SynCardia Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Without Environmental Hygiene, Hand Hygiene Programs Fall Short in Reducing HAIs in Hospital Settings, Says UMF Corporation
2. LIVE VIA SATELLITE: Physician Demonstrates New Medical Technology to Combat Back Pain without Major Surgery
3. Man Without Human Heart Hikes More Than 400 Miles
4. Homecare Community Dismayed that Medicare Will Start Prior Authorization for Wheelchairs without a Clinical Template for Physicians to Document Need
5. RMANJ Research Demonstrates That Egg Freezing Prior To IVF Yields Positive Outcomes Without Increasing Risk Of Aneuploidy
6. Mount Sinai Medical Center 1st in Tri-State Area to Discharge Patient without Human Heart
7. Netsmarts Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment
8. SMT C1100 For Duchenne Muscular Dystrophy Moves To Human Testing
9. Global Human Vaccines Industry
10. ReproCELL Launches Alzheimers Disease Model Based on iPS-derived Human Neuronal Cells
11. HemoShear Publishes Key Review on Human-Relevant Organotypic Systems
Post Your Comments:
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma ... as the company,s second affiliate in Latin America . ... ... Astellas Farma Colombia ... ...
(Date:6/23/2016)... , June 23, 2016 ... "Surgical Procedure Volumes: Global Analysis (United States, China, ... Canada)" report to their offering. ... essential tool for healthcare business planners, provides surgical procedure ... at surgery trends with an in-depth analysis of growth ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... recently awarded their highest five-star rating ... Millions of individuals in the United States and Canada wear eyeglasses. Once considered to ... correct vision and make a fashion statement. Even celebrities use glasses as a way ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
Breaking Medicine News(10 mins):